Bydureon BCise (Extended-Release Exenatide) Bydureon BCise delivers exenatide, a synthetic version of a hormone found in Gila monster venom
We look forward to continuing to collaborate with study investigators and the PBH community as we seek to initiate LUCIDITY and advance avexitide through the clinical development process. Sources Amylyx Pharmaceuticals Appoints Dan Monahan as Chief Commercial Officer
September 18, 2025: Still Awaiting New Jersey Decision on Vision Loss Lawsuits We are still awaiting word from the New Jersey Supreme Court on whether or not Ozempic vision loss lawsuits will be grouped together into an MCL
It's a dietary supplement, not reviewed or approved by the FDA, and not intended to diagnose, treat, cure, or prevent any disease
Medical weight loss with GLP-1 receptor agonist medications is a clinician-supervised program that uses semaglutide or tirzepatide to reduce appetite, regulate blood sugar, and promote sustained fat loss